Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses
S Connelly, S Choi, SM Johnson, JW Kelly… - Current opinion in …, 2010 - Elsevier
Small molecules that bind to normally unoccupied thyroxine (T4) binding sites within
transthyretin (TTR) in the blood stabilize the tetrameric ground state of TTR relative to the …
transthyretin (TTR) in the blood stabilize the tetrameric ground state of TTR relative to the …
Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses
Y Sekijima, JW Kelly, S Ikeda - Current pharmaceutical design, 2008 - ingentaconnect.com
Transthyretin (TTR) is a homotetrameric serum and cerebrospinal fluid protein that
transports both thyroxine (T4) and the retinol-retinol binding protein complex (holoRBP) …
transports both thyroxine (T4) and the retinol-retinol binding protein complex (holoRBP) …
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
R Sant'Anna, P Gallego, LZ Robinson… - Nature …, 2016 - nature.com
Transthyretin (TTR) is a plasma homotetrameric protein implicated in fatal systemic
amyloidoses. TTR tetramer dissociation precedes pathological TTR aggregation. Native …
amyloidoses. TTR tetramer dissociation precedes pathological TTR aggregation. Native …
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis
Y Sekijima, MA Dendle, JW Kelly - Amyloid, 2006 - Taylor & Francis
Objective. Rate-limiting transthyretin (TTR) tetramer dissociation and monomer misfolding
enable misassembly into numerous aggregate morphologies including amyloid, a process …
enable misassembly into numerous aggregate morphologies including amyloid, a process …
[HTML][HTML] Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
N Ferreira, MJ Saraiva, MR Almeida - FEBS letters, 2011 - Elsevier
Several natural polyphenols with potent inhibitory effects on amyloid fibril formation have
been reported. Herein, we studied modulation of transthyretin (TTR) fibrillogenesis by …
been reported. Herein, we studied modulation of transthyretin (TTR) fibrillogenesis by …
[HTML][HTML] Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity
More than 100 transthyretin (TTR) variants are associated with hereditary amyloidosis.
Approaches for TTR amyloidosis that interfere with any step of the cascade of events leading …
Approaches for TTR amyloidosis that interfere with any step of the cascade of events leading …
Undiscovered roles for transthyretin: from a transporter protein to a new therapeutic target for Alzheimer's disease
T Gião, J Saavedra, E Cotrina, J Quintana… - International journal of …, 2020 - mdpi.com
Transthyretin (TTR), an homotetrameric protein mainly synthesized by the liver and the
choroid plexus, and secreted into the blood and the cerebrospinal fluid, respectively, has …
choroid plexus, and secreted into the blood and the cerebrospinal fluid, respectively, has …
Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran
M Rizk, Ş Tüzmen - Pharmacogenomics and personalized …, 2017 - Taylor & Francis
RNA interference (RNAi) is a naturally existing endogenous mechanism for post-
transcriptional gene regulation, nowadays commonly utilized for functional characterization …
transcriptional gene regulation, nowadays commonly utilized for functional characterization …
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis:“in vivo” evidence from FAP mice models
N Ferreira, MJ Saraiva, MR Almeida - PloS one, 2012 - journals.plos.org
Background Familial amyloidotic polyneuropathy (FAP) is a neurodegenerative disease
caused by the extracellular deposition of mutant transthyretin (TTR), with special …
caused by the extracellular deposition of mutant transthyretin (TTR), with special …
Treatment of transthyretin amyloid cardiomyopathy: the current options, the future, and the challenges
C Tschöpe, A Elsanhoury - Journal of Clinical Medicine, 2022 - mdpi.com
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressively debilitating, rare
disease associated with high mortality. ATTR-CM occurs when TTR amyloid protein builds …
disease associated with high mortality. ATTR-CM occurs when TTR amyloid protein builds …